-
Je něco špatně v tomto záznamu ?
A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats
der Zee J van, I Gijselinck, L Dillen, Langenhove T Van, J Theuns, S Engelborghs, S Philtjens, M Vandenbulcke, K Sleegers, A Sieben, V Baumer, G Maes, E Corsmit, B Borroni, A Padovani, S Archetti, R Perneczky, J Diehl-Schmid, Mendonca A de, G...
Jazyk angličtina Země Spojené státy americké
Grantová podpora
NT12094
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
Medline Complete (EBSCOhost)
od 2012-07-01
PubMed
23111906
DOI
10.1002/humu.22244
Knihovny.cz E-zdroje
- MeSH
- alely MeSH
- Alzheimerova nemoc genetika MeSH
- celogenomová asociační studie metody MeSH
- dospělí MeSH
- expanze repetic DNA MeSH
- frontotemporální lobární degenerace * epidemiologie genetika MeSH
- haplotypy MeSH
- kohortové studie MeSH
- lidé středního věku MeSH
- lidé MeSH
- lidské chromozomy, pár 9 genetika MeSH
- molekulární sekvence - údaje MeSH
- nestabilita genomu * MeSH
- prevalence MeSH
- protein C9orf72 MeSH
- proteiny * genetika MeSH
- sekvence nukleotidů MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- věk při počátku nemoci MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- Geografické názvy
- Evropa MeSH
- Finsko MeSH
- Německo MeSH
- Španělsko MeSH
- Švédsko MeSH
We assessed the geographical distribution of C9orf72 G(4) C(2) expansions in a pan-European frontotemporal lobar degeneration (FTLD) cohort (n = 1,205), ascertained by the European Early-Onset Dementia (EOD) consortium. Next, we performed a meta-analysis of our data and that of other European studies, together 2,668 patients from 15 Western European countries. The frequency of the C9orf72 expansions in Western Europe was 9.98% in overall FTLD, with 18.52% in familial, and 6.26% in sporadic FTLD patients. Outliers were Finland and Sweden with overall frequencies of respectively 29.33% and 20.73%, but also Spain with 25.49%. In contrast, prevalence in Germany was limited to 4.82%. In addition, we studied the role of intermediate repeats (7-24 repeat units), which are strongly correlated with the risk haplotype, on disease and C9orf72 expression. In vitro reporter gene expression studies demonstrated significantly decreased transcriptional activity of C9orf72 with increasing number of normal repeat units, indicating that intermediate repeats might act as predisposing alleles and in favor of the loss-of-function disease mechanism. Further, we observed a significantly increased frequency of short indels in the GC-rich low complexity sequence adjacent to the G(4) C(2) repeat in C9orf72 expansion carriers (P < 0.001) with the most common indel creating one long contiguous imperfect G(4) C(2) repeat, which is likely more prone to replication slippage and pathological expansion.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18035065
- 003
- CZ-PrNML
- 005
- 20181017135844.0
- 007
- ta
- 008
- 181017s2013 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/humu.22244 $2 doi
- 035 __
- $a (PubMed)23111906
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a van der Zee J $u van der Zee, Julie. Department of Molecular Genetics, VIB, Antwerp, Belgium.
- 245 12
- $a A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats / $c der Zee J van, I Gijselinck, L Dillen, Langenhove T Van, J Theuns, S Engelborghs, S Philtjens, M Vandenbulcke, K Sleegers, A Sieben, V Baumer, G Maes, E Corsmit, B Borroni, A Padovani, S Archetti, R Perneczky, J Diehl-Schmid, Mendonca A de, G Miltenberger-Miltenyi, S Pereira, J Pimentel, B Nacmias, S Bagnoli, S Sorbi, C Graff, HH Chiang, M Westerlund, R Sanchez-Valle, A Llado, E Gelpi, I Santana, MR Almeida, B Santiago, G Frisoni, O Zanetti, C Bonvicini, M Synofzik, W Maetzler, Hagen JM Vom, L Schols, MT Heneka, F Jessen, R Matej, E Parobkova, GG Kovacs, T Strobel, S Sarafov, I Tournev, A Jordanova, A Danek, T Arzberger, GM Fabrizi, S Testi, E Salmon, P Santens, JJ Martin, P Cras, R Vandenberghe, Deyn PP De, M Cruts, Broeckhoven C Van, der Zee J van, I Gijselinck, L Dillen, Langenhove T Van, J Theuns, S Philtjens, K Sleegers, V Baumer, G Maes, E Corsmit, M Cruts, Broeckhoven C Van, der Zee J van, I Gijselinck, L Dillen, Langenhove T Van, S Philtjens, J Theuns, K Sleegers, V Baumer, G Maes, M Cruts, Broeckhoven C Van, S Engelborghs, Deyn PP De, P Cras, S Engelborghs, Deyn PP De, M Vandenbulcke, M Vandenbulcke, B Borroni, A Padovani, S Archetti, R Perneczky, J Diehl-Schmid, M Synofzik, W Maetzler, Vom Hagen J Muller, L Schols, M Synofzik, W Maetzler, Vom Hagen J Muller, L Schols, MT Heneka, F Jessen, A Ramirez, D Kurzwelly, C Sachtleben, W Mairer, Mendonca A de, G Miltenberger-Miltenyi, S Pereira, C Firmo, J Pimentel, R Sanchez-Valle, A Llado, A Antonell, J Molinuevo, E Gelpi, C Graff, HH Chiang, M Westerlund, C Graff, Stahlbom A Kinhult, H Thonberg, I Nennesmo, A Borjesson-Hanson, B Nacmias, S Bagnoli, S Sorbi, V Bessi, I Piaceri, I Santana, B Santiago, I Santana, Ribeiro M Helena, Almeida M Rosario, C Oliveira, J Massano, C Garret, P Pires, G Frisoni, O Zanetti, C Bonvicini, S Sarafov, I Tournev, A Jordanova, I Tournev, GG Kovacs, T Strobel, MT Heneka, F Jessen, A Ramirez, D Kurzwelly, C Sachtleben, W Mairer, F Jessen, R Matej, E Parobkova, A Danel, T Arzberger, Fabrizi G Maria, S Testi, S Ferrari, T Cavallaro, E Salmon, P Santens, P Cras, Early-Onset Dementia Consortium European
- 520 9_
- $a We assessed the geographical distribution of C9orf72 G(4) C(2) expansions in a pan-European frontotemporal lobar degeneration (FTLD) cohort (n = 1,205), ascertained by the European Early-Onset Dementia (EOD) consortium. Next, we performed a meta-analysis of our data and that of other European studies, together 2,668 patients from 15 Western European countries. The frequency of the C9orf72 expansions in Western Europe was 9.98% in overall FTLD, with 18.52% in familial, and 6.26% in sporadic FTLD patients. Outliers were Finland and Sweden with overall frequencies of respectively 29.33% and 20.73%, but also Spain with 25.49%. In contrast, prevalence in Germany was limited to 4.82%. In addition, we studied the role of intermediate repeats (7-24 repeat units), which are strongly correlated with the risk haplotype, on disease and C9orf72 expression. In vitro reporter gene expression studies demonstrated significantly decreased transcriptional activity of C9orf72 with increasing number of normal repeat units, indicating that intermediate repeats might act as predisposing alleles and in favor of the loss-of-function disease mechanism. Further, we observed a significantly increased frequency of short indels in the GC-rich low complexity sequence adjacent to the G(4) C(2) repeat in C9orf72 expansion carriers (P < 0.001) with the most common indel creating one long contiguous imperfect G(4) C(2) repeat, which is likely more prone to replication slippage and pathological expansion.<ovid:br /><ovid:br />Copyright © 2012 Wiley Periodicals, Inc.
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a dospělí $7 D000328
- 650 02
- $a věk při počátku nemoci $7 D017668
- 650 02
- $a senioři $7 D000368
- 650 02
- $a senioři nad 80 let $7 D000369
- 650 02
- $a alely $7 D000483
- 650 02
- $a Alzheimerova nemoc $x genetika $7 D000544
- 650 02
- $a sekvence nukleotidů $7 D001483
- 650 02
- $a protein C9orf72 $7 D000073885
- 650 02
- $a lidské chromozomy, pár 9 $x genetika $7 D002899
- 650 02
- $a kohortové studie $7 D015331
- 650 02
- $a expanze repetic DNA $7 D042622
- 650 12
- $a frontotemporální lobární degenerace $x epidemiologie $x genetika $7 D057174
- 650 02
- $a celogenomová asociační studie $x metody $7 D055106
- 650 12
- $a nestabilita genomu $7 D042822
- 650 02
- $a haplotypy $7 D006239
- 650 02
- $a lidé $7 D006801
- 650 02
- $a lidé středního věku $7 D008875
- 650 02
- $a molekulární sekvence - údaje $7 D008969
- 650 02
- $a prevalence $7 D015995
- 650 12
- $a proteiny $x genetika $7 D011506
- 651 _2
- $a Švédsko $x epidemiologie $7 D013548
- 651 _2
- $a Španělsko $x epidemiologie $7 D013030
- 651 _2
- $a Evropa $x epidemiologie $7 D005060
- 651 _2
- $a Finsko $x epidemiologie $7 D005387
- 651 _2
- $a Německo $x epidemiologie $7 D005858
- 700 1_
- $a Gijselinck I
- 700 1_
- $a Dillen L
- 700 1_
- $a Van Langenhove T
- 700 1_
- $a Theuns J
- 700 1_
- $a Engelborghs S
- 700 1_
- $a Philtjens S
- 700 1_
- $a Vandenbulcke M
- 700 1_
- $a Sleegers K
- 700 1_
- $a Sieben A
- 700 1_
- $a Baumer V
- 700 1_
- $a Maes G
- 700 1_
- $a Corsmit E
- 700 1_
- $a Borroni B
- 700 1_
- $a Padovani A
- 700 1_
- $a Archetti S
- 700 1_
- $a Perneczky R
- 700 1_
- $a Diehl-Schmid J
- 700 1_
- $a de Mendonca A
- 700 1_
- $a Miltenberger-Miltenyi G
- 700 1_
- $a Pereira S
- 700 1_
- $a Pimentel J
- 700 1_
- $a Nacmias B
- 700 1_
- $a Bagnoli S
- 700 1_
- $a Sorbi S
- 700 1_
- $a Graff C
- 700 1_
- $a Chiang HH
- 700 1_
- $a Westerlund M
- 700 1_
- $a Sanchez-Valle R
- 700 1_
- $a Llado A
- 700 1_
- $a Gelpi E
- 700 1_
- $a Santana I
- 700 1_
- $a Almeida MR
- 700 1_
- $a Santiago B
- 700 1_
- $a Frisoni G
- 700 1_
- $a Zanetti O
- 700 1_
- $a Bonvicini C
- 700 1_
- $a Synofzik M
- 700 1_
- $a Maetzler W
- 700 1_
- $a Vom Hagen JM
- 700 1_
- $a Schols L
- 700 1_
- $a Heneka MT
- 700 1_
- $a Jessen F
- 700 1_
- $a Matej R
- 700 1_
- $a Parobkova E
- 700 1_
- $a Kovacs GG
- 700 1_
- $a Strobel T
- 700 1_
- $a Sarafov S
- 700 1_
- $a Tournev I
- 700 1_
- $a Jordanova A
- 700 1_
- $a Danek A
- 700 1_
- $a Arzberger T
- 700 1_
- $a Fabrizi GM
- 700 1_
- $a Testi S
- 700 1_
- $a Salmon E
- 700 1_
- $a Santens P
- 700 1_
- $a Martin JJ
- 700 1_
- $a Cras P
- 700 1_
- $a Vandenberghe R
- 700 1_
- $a De Deyn PP
- 700 1_
- $a Cruts M
- 700 1_
- $a Van Broeckhoven C
- 700 1_
- $a van der Zee J
- 700 1_
- $a Gijselinck I
- 700 1_
- $a Dillen L
- 700 1_
- $a Van Langenhove T
- 700 1_
- $a Theuns J
- 700 1_
- $a Philtjens S
- 700 1_
- $a Sleegers K
- 700 1_
- $a Baumer V
- 700 1_
- $a Maes G
- 700 1_
- $a Corsmit E
- 700 1_
- $a Cruts M
- 700 1_
- $a Van Broeckhoven C
- 700 1_
- $a van der Zee J
- 700 1_
- $a Gijselinck I
- 700 1_
- $a Dillen L
- 700 1_
- $a Van Langenhove T
- 700 1_
- $a Philtjens S
- 700 1_
- $a Theuns J
- 700 1_
- $a Sleegers K
- 700 1_
- $a Baumer V
- 700 1_
- $a Maes G
- 700 1_
- $a Cruts M
- 700 1_
- $a Van Broeckhoven C
- 700 1_
- $a Engelborghs S
- 700 1_
- $a De Deyn PP
- 700 1_
- $a Cras P
- 700 1_
- $a Engelborghs S
- 700 1_
- $a De Deyn PP
- 700 1_
- $a Vandenbulcke M
- 700 1_
- $a Vandenbulcke M
- 700 1_
- $a Borroni B
- 700 1_
- $a Padovani A
- 700 1_
- $a Archetti S
- 700 1_
- $a Perneczky R
- 700 1_
- $a Diehl-Schmid J
- 700 1_
- $a Synofzik M
- 700 1_
- $a Maetzler W
- 700 1_
- $a Muller Vom Hagen J
- 700 1_
- $a Schols L
- 700 1_
- $a Synofzik M
- 700 1_
- $a Maetzler W
- 700 1_
- $a Muller Vom Hagen J
- 700 1_
- $a Schols L
- 700 1_
- $a Heneka MT
- 700 1_
- $a Jessen F
- 700 1_
- $a Ramirez A
- 700 1_
- $a Kurzwelly D
- 700 1_
- $a Sachtleben C
- 700 1_
- $a Mairer W
- 700 1_
- $a de Mendonca A
- 700 1_
- $a Miltenberger-Miltenyi G
- 700 1_
- $a Pereira S
- 700 1_
- $a Firmo C
- 700 1_
- $a Pimentel J
- 700 1_
- $a Sanchez-Valle R
- 700 1_
- $a Llado A
- 700 1_
- $a Antonell A
- 700 1_
- $a Molinuevo J
- 700 1_
- $a Gelpi E
- 700 1_
- $a Graff C
- 700 1_
- $a Chiang HH
- 700 1_
- $a Westerlund M
- 700 1_
- $a Graff C
- 700 1_
- $a Kinhult Stahlbom A
- 700 1_
- $a Thonberg H
- 700 1_
- $a Nennesmo I
- 700 1_
- $a Borjesson-Hanson A
- 700 1_
- $a Nacmias B
- 700 1_
- $a Bagnoli S
- 700 1_
- $a Sorbi S
- 700 1_
- $a Bessi V
- 700 1_
- $a Piaceri I
- 700 1_
- $a Santana I
- 700 1_
- $a Santiago B
- 700 1_
- $a Santana I
- 700 1_
- $a Helena Ribeiro M
- 700 1_
- $a Rosario Almeida M
- 700 1_
- $a Oliveira C
- 700 1_
- $a Massano J
- 700 1_
- $a Garret C
- 700 1_
- $a Pires P
- 700 1_
- $a Frisoni G
- 700 1_
- $a Zanetti O
- 700 1_
- $a Bonvicini C
- 700 1_
- $a Sarafov S
- 700 1_
- $a Tournev I
- 700 1_
- $a Jordanova A
- 700 1_
- $a Tournev I
- 700 1_
- $a Kovacs GG
- 700 1_
- $a Strobel T
- 700 1_
- $a Heneka MT
- 700 1_
- $a Jessen F
- 700 1_
- $a Ramirez A
- 700 1_
- $a Kurzwelly D
- 700 1_
- $a Sachtleben C
- 700 1_
- $a Mairer W
- 700 1_
- $a Jessen F
- 700 1_
- $a Matej R
- 700 1_
- $a Parobkova E
- 700 1_
- $a Danel A
- 700 1_
- $a Arzberger T
- 700 1_
- $a Maria Fabrizi G
- 700 1_
- $a Testi S
- 700 1_
- $a Ferrari S
- 700 1_
- $a Cavallaro T
- 700 1_
- $a Salmon E
- 700 1_
- $a Santens P
- 700 1_
- $a Cras P
- 700 1_
- $a European Early-Onset Dementia Consortium
- 773 0_
- $t Human Mutation $g Roč. 34, č. 2 (2013), s. 363-373 $p Hum Mutat $x 1059-7794 $w MED00002078
- 773 0_
- $p Hum Mutat $g 34(2):363-73, 2013 Feb
- 910 __
- $a ABA008 $y 4 $z 0
- 990 __
- $a 20181017135744 $b ABA008
- 991 __
- $a 20181017140343 $b ABA008
- 999 __
- $a ok $b bmc $g 1343656 $s 1032066
- BAS __
- $a 3
- BMC __
- $a 2013 $b 34 $c 2 $d 363-373 $x MED00002078 $i 1059-7794 $m Human mutation
- GRA __
- $a NT12094 $p MZ0
- LZP __
- $a NLK 2018/lp